Search by Drug Name or NDC
NDC 17433-9877-03 ENEMEEZ Plus 20; 283 mg/5mL; mg/5mL Details
ENEMEEZ Plus 20; 283 mg/5mL; mg/5mL
ENEMEEZ Plus is a RECTAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Enemeez LLC DBA Summit Pharmaceuticals. The primary component is BENZOCAINE; DOCUSATE SODIUM.
Product Information
| NDC | 17433-9877 |
|---|---|
| Product ID | 17433-9877_0555d5ed-ff59-3e3c-e063-6294a90a9949 |
| Associated GPIs | 46500010055120 |
| GCN Sequence Number | 068186 |
| GCN Sequence Number Description | docusate sodium/benzocaine ENEMA 283-20MG/5 RECTAL |
| HIC3 | Q3S |
| HIC3 Description | LAXATIVES, LOCAL/RECTAL |
| GCN | 30915 |
| HICL Sequence Number | 001321 |
| HICL Sequence Number Description | DOCUSATE SODIUM/BENZOCAINE |
| Brand/Generic | Brand |
| Proprietary Name | ENEMEEZ Plus |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | docusate sodium and benzocaine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | RECTAL |
| Active Ingredient Strength | 20; 283 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | BENZOCAINE; DOCUSATE SODIUM |
| Labeler Name | Enemeez LLC DBA Summit Pharmaceuticals |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 17433-9877-03 (17433987703)
| NDC Package Code | 17433-9877-3 |
|---|---|
| Billing NDC | 17433987703 |
| Package | 30 TUBE in 1 CONTAINER (17433-9877-3) / 5 mL in 1 TUBE (17433-9877-0) |
| Marketing Start Date | 2012-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.36172 |
| Pricing Unit | ML |
| Effective Date | 2023-08-23 |
| NDC Description | ENEMEEZ PLUS MINI ENEMA |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4, 5, 6 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis